Notable 52-Week Highs and Lows 9/27: (ARRY) (NVDA) (ERII) High; (CVM) (VNR) Low

September 27, 2016 3:28 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

52-Week High:
  • Array BioPharma Inc. (Nasdaq: ARRY) $7.27. Array BioPharma continuing higher from Monday following strong Phase 3 COLUMBUS results. Jefferies lifted its price target on the stock from $7 to $8.

  • NVIDIA (Nasdaq: NVDA) $. NVIDIA seeing continued momentum as the stock moves to all-time highs. Shares are up nearly 100 percent year-to-date 2016.

  • Energy Recovery (Nasdaq: ERII) $16.66. Evercore ISI initiated coverage on Energy Recovery with a Buy rating and a price target of $23 today. For more color, click here.
52-Week Low:
  • CEL-SCI Corporation (NYSE: CVM) $0.24. CEL-SCI announced that it has received verbal notice from the U.S. Food and Drug Administration (FDA) that its Multikine (Leukocyte Interleukin Injection) Phase 3 clinical trial in advanced primary head and neck cancer has been placed on clinical hold. Pursuant to this communication from FDA, patients currently receiving study treatments can continue to receive treatment, and patients already enrolled in the study will continue to be followed. CEL-SCI was also told to expect a formal letter from the FDA within 30 days and will work diligently with the FDA to obtain the release of the clinical hold. The study currently has about 926 patients enrolled.

  • Vanguard Natural Resources (Nasdaq: VNR) $0.86. Hilliard Lyons downgraded Vanguard Natural Resources from Long-Term Buy to Neutral and removed its $12 price target.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Special Reports

Related Entities

Jefferies & Co, Hilliard Lyons, Vanguard

Add Your Comment